Our writers have been following CanaFarma Hemp Products Corp (CNFA) as they go through the process of trading public shares in Canada, Germany, and Mexico. Currently, they are in 2 of 3 as we enter Q2, 2020.

Remarkably the company is plodding along in one of the worst environments in a century. Pre-launch the company expected to have $100m valuation, and they are currently tracking a bit above, but based on liquidity and market uncertainty they are keeping the course.

We think the upcoming listing in Mexico will expand shareholder base for them

You can click here for Frankfurt Quote, and here for Canada.

We spoke to the company in January click below to listen to the podcast with Vitaly Fargesen who was looking for a valuation near $100 million based on the sales of Yoofiric Gum, and the team’s experience.

The companies value today is (based on last sale) is $130 Million so they were not far off in their expectations. They seemed to understand prior to launch how the market is assigning multiples to the industry. But we venture no one would have predicted Cannabis Sector Stock would hold multiples during the Covid-19 environment for public companies.

Click below to listen to Vitaly Fargesen Podcast

MARKET NEWS FIRST (MN1.COM) INTERVIEW WITH VITALY FARGESEN OF CANAFARMA CORP is a wide-ranging Q&A with Vitaly Fargesen with MN1 host Josh Lankford explaining company strategy for 2020. Click here to listen to the interview.

Click below to listen to Frank Barone podcast on Sales and Marketing

MASTER OF DIRECT TO CONSUMER (D2C) SALES is an interview with Frank Barone who provides leadership in the affiliate marketing program and strategy at the company. It is an informative view from inside the company spoken clearly by Mr. Barone. Click here to listen to the interview.

The companies value today is (based on the last sale) is $130 Million so they were not far off in their expectations. They seemed to understand prior to launch how the market was assigning multiples to the industry. But we venture no one would have predicted Cannabis Sector Stock would hold multiples during the COVID-19 environment for public companies.

Authors